Terms: = Kidney tumors AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Clinical Outcome
17 results:
1. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
2. Human Polyomavirus Is Associated With Earlier Onset of Upper Urinary Tract Urothelial Carcinoma in Patients After kidney Transplantation.
Luo HL; Chen YT; Huang SC; Chen TC; Chiang PH; Lin SS; Cheng YT
Transplant Proc; 2017 Jun; 49(5):1064-1067. PubMed ID: 28583528
[TBL] [Abstract] [Full Text] [Related]
3. High Level of Anaphylatoxin C5a Predicts Poor clinical outcome in Patients with Clear Cell Renal Cell Carcinoma.
Xi W; Liu L; Wang J; Xia Y; Bai Q; Long Q; Wang Y; Xu J; Guo J
Sci Rep; 2016 Jul; 6():29177. PubMed ID: 27381421
[TBL] [Abstract] [Full Text] [Related]
4. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract] [Full Text] [Related]
6. The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry database.
Vaishampayan U; Vankayala H; Vigneau FD; Quarshie W; Dickow B; Chalasani S; Schwartz K
Clin Genitourin Cancer; 2014 Apr; 12(2):124-9. PubMed ID: 24225251
[TBL] [Abstract] [Full Text] [Related]
7. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.
Sun D; Lu J; Ding K; Bi D; Niu Z; Cao Q; Zhang J; Ding S
Med Oncol; 2013 Mar; 30(1):476. PubMed ID: 23371254
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of surgical treatment and effect of spinal metastatic tumors].
Ye SM; Qi XS; Mao ZX; Wang QM; Wei XC
Zhongguo Gu Shang; 2011 Dec; 24(12):977-81. PubMed ID: 22276502
[TBL] [Abstract] [Full Text] [Related]
9. Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size.
Mondal SK
Diagn Cytopathol; 2012 Dec; 40(12):1083-7. PubMed ID: 21563327
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy.
Vickers MM; Choueiri TK; Rogers M; Percy A; Finch D; Zama I; Cheng T; North S; Knox JJ; Kollmannsberger C; McDermott DF; Rini BI; Heng DY
Urology; 2010 Aug; 76(2):430-4. PubMed ID: 20223508
[TBL] [Abstract] [Full Text] [Related]
11. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
[TBL] [Abstract] [Full Text] [Related]
14. Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours.
Kwon EO; Carver BS; Snyder ME; Russo P
BJU Int; 2007 Feb; 99(2):286-9. PubMed ID: 17155985
[TBL] [Abstract] [Full Text] [Related]
15. Transureteroureterostomy allows renal sparing radical resection of advanced malignancies with rectosigmoid invasion.
Richter S; Kollmar O; Lindemann W; Schilling MK
Int J Colorectal Dis; 2007 Aug; 22(8):949-53. PubMed ID: 17119984
[TBL] [Abstract] [Full Text] [Related]
16. A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses.
O'Malley RL; Berger AD; Kanofsky JA; Phillips CK; Stifelman M; Taneja SS
BJU Int; 2007 Feb; 99(2):395-8. PubMed ID: 17092288
[TBL] [Abstract] [Full Text] [Related]
17. Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature.
Jewett M; Rendon R; Dranitsaris G; Drachenberg D; Tanguay S; Donnelly B; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():54-61. PubMed ID: 16818013
[TBL] [Abstract] [Full Text] [Related]
